BR112015003824A2 - composto; método de tratamento de uma amiloidose em um indivíduo; composição farmacêutica; e método para tratar uma condição que é um membro selecionado da perda de memória, perda de cognição e uma combinação destas. - Google Patents
composto; método de tratamento de uma amiloidose em um indivíduo; composição farmacêutica; e método para tratar uma condição que é um membro selecionado da perda de memória, perda de cognição e uma combinação destas.Info
- Publication number
- BR112015003824A2 BR112015003824A2 BR112015003824A BR112015003824A BR112015003824A2 BR 112015003824 A2 BR112015003824 A2 BR 112015003824A2 BR 112015003824 A BR112015003824 A BR 112015003824A BR 112015003824 A BR112015003824 A BR 112015003824A BR 112015003824 A2 BR112015003824 A2 BR 112015003824A2
- Authority
- BR
- Brazil
- Prior art keywords
- treating
- loss
- amyloidosis
- individual
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- E—FIXED CONSTRUCTIONS
- E21—EARTH DRILLING; MINING
- E21B—EARTH DRILLING, e.g. DEEP DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS
- E21B36/00—Heating, cooling, insulating arrangements for boreholes or wells, e.g. for use in permafrost zones
- E21B36/001—Cooling arrangements
-
- E—FIXED CONSTRUCTIONS
- E21—EARTH DRILLING; MINING
- E21B—EARTH DRILLING, e.g. DEEP DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS
- E21B36/00—Heating, cooling, insulating arrangements for boreholes or wells, e.g. for use in permafrost zones
- E21B36/003—Insulating arrangements
-
- E—FIXED CONSTRUCTIONS
- E21—EARTH DRILLING; MINING
- E21B—EARTH DRILLING, e.g. DEEP DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS
- E21B36/00—Heating, cooling, insulating arrangements for boreholes or wells, e.g. for use in permafrost zones
- E21B36/04—Heating, cooling, insulating arrangements for boreholes or wells, e.g. for use in permafrost zones using electrical heaters
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
- F16L11/00—Hoses, i.e. flexible pipes
- F16L11/20—Double-walled hoses, i.e. two concentric hoses
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
- F16L53/00—Heating of pipes or pipe systems; Cooling of pipes or pipe systems
- F16L53/30—Heating of pipes or pipe systems
- F16L53/35—Ohmic-resistance heating
- F16L53/38—Ohmic-resistance heating using elongate electric heating elements, e.g. wires or ribbons
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
- F16L9/00—Rigid pipes
- F16L9/18—Double-walled pipes; Multi-channel pipes or pipe assemblies
- F16L9/19—Multi-channel pipes or pipe assemblies
- F16L9/20—Pipe assemblies
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02G—INSTALLATION OF ELECTRIC CABLES OR LINES, OR OF COMBINED OPTICAL AND ELECTRIC CABLES OR LINES
- H02G3/00—Installations of electric cables or lines or protective tubing therefor in or on buildings, equivalent structures or vehicles
- H02G3/36—Installations of cables or lines in walls, floors or ceilings
- H02G3/38—Installations of cables or lines in walls, floors or ceilings the cables or lines being installed in preestablished conduits or ducts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mining & Mineral Resources (AREA)
- Geology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Geochemistry & Mineralogy (AREA)
- Fluid Mechanics (AREA)
- Environmental & Geological Engineering (AREA)
- Mechanical Engineering (AREA)
- Health & Medical Sciences (AREA)
- Architecture (AREA)
- Civil Engineering (AREA)
- Structural Engineering (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Laying Of Electric Cables Or Lines Outside (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261693011P | 2012-08-24 | 2012-08-24 | |
| US61/693,011 | 2012-08-24 | ||
| PCT/US2013/056220 WO2014031873A2 (en) | 2012-08-24 | 2013-08-22 | Benzofurazan anti-amyloid compounds and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112015003824A2 true BR112015003824A2 (pt) | 2018-05-29 |
| BR112015003824B1 BR112015003824B1 (pt) | 2022-10-04 |
Family
ID=50150397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015003824-7A BR112015003824B1 (pt) | 2012-08-24 | 2013-08-22 | Composto, composição farmacêutica e uso do composto |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US9328078B2 (pt) |
| EP (1) | EP2888252B1 (pt) |
| JP (1) | JP6219955B2 (pt) |
| KR (1) | KR102046499B1 (pt) |
| CN (1) | CN104768949A (pt) |
| AU (1) | AU2013305663B2 (pt) |
| BR (1) | BR112015003824B1 (pt) |
| CA (1) | CA2883221C (pt) |
| IL (1) | IL237305B (pt) |
| MX (1) | MX365851B (pt) |
| NZ (1) | NZ705167A (pt) |
| RU (1) | RU2641293C2 (pt) |
| WO (2) | WO2014031873A2 (pt) |
| ZA (1) | ZA201501161B (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3110812T (pt) * | 2014-02-27 | 2019-07-10 | Treventis Corp | Compostos antiamiloide contendo benzofurazano |
| DE102014214687A1 (de) * | 2014-07-25 | 2016-01-28 | Contitech Techno-Chemie Gmbh | Beheizbarer Schlauch |
| US11040994B2 (en) | 2017-06-06 | 2021-06-22 | Council Of Scientific And Industrial Research | Cobalt complexes, process for preparation and use thereof |
| CN108566693B (zh) * | 2017-11-27 | 2020-12-25 | 安邦电气股份有限公司 | 一种高效率伴热带 |
| CN108235475B (zh) * | 2017-11-27 | 2021-01-22 | 安邦电气股份有限公司 | 一种便于使用的伴热带 |
| WO2022015859A1 (en) * | 2020-07-14 | 2022-01-20 | Washington University | Compositions for cancer therapy and imaging |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3971416A (en) * | 1974-08-16 | 1976-07-27 | Thermon Manufacturing Company | Preinsulated pipe assembly and pipeline |
| DE19643037A1 (de) * | 1996-10-18 | 1998-04-23 | Boehringer Ingelheim Kg | Neue Oxadiazole, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
| JP2002228081A (ja) * | 2001-02-06 | 2002-08-14 | Nitta Moore Co | 保温・移送用配管 |
| CA2467081A1 (en) * | 2001-11-14 | 2003-05-22 | Henning Boettcher | Pyrazole derivatives as psychopharmaceuticals |
| JP2003328402A (ja) * | 2002-05-16 | 2003-11-19 | Sekisui Chem Co Ltd | ヒータ挿入ガイド付き管 |
| GB0228410D0 (en) * | 2002-12-05 | 2003-01-08 | Glaxo Group Ltd | Novel Compounds |
| JP2004244958A (ja) * | 2003-02-14 | 2004-09-02 | Sekisui Chem Co Ltd | 凍結防止用流水配管 |
| GB0328900D0 (en) * | 2003-12-12 | 2004-01-14 | Glaxo Group Ltd | Novel compounds |
| JP2008503591A (ja) | 2004-06-22 | 2008-02-07 | ライジェル ファーマシューティカルズ， インコーポレイテッド | ユビキチンリガーゼ阻害剤 |
| GB2423811A (en) * | 2005-03-02 | 2006-09-06 | Valpar Ind Ltd | Improved Beverage Python |
| CN102170882B (zh) * | 2008-08-29 | 2014-04-02 | 特温蒂斯公司 | 治疗淀粉状蛋白疾病的组合物和其制药用途 |
| CA2818903C (en) * | 2010-12-14 | 2021-03-23 | Electrophoretics Limited | 5-(1,3-benzoxazol-2-yl)-4-(pyridin-4-yl)pyrimidin-2-amine and its use as a casein kinase 1delta inhibitor |
-
2013
- 2013-08-22 BR BR112015003824-7A patent/BR112015003824B1/pt active IP Right Grant
- 2013-08-22 MX MX2015002418A patent/MX365851B/es active IP Right Grant
- 2013-08-22 RU RU2015110256A patent/RU2641293C2/ru active
- 2013-08-22 CN CN201380055866.6A patent/CN104768949A/zh active Pending
- 2013-08-22 US US14/422,669 patent/US9328078B2/en active Active
- 2013-08-22 KR KR1020157007368A patent/KR102046499B1/ko active IP Right Grant
- 2013-08-22 CA CA2883221A patent/CA2883221C/en active Active
- 2013-08-22 JP JP2015528656A patent/JP6219955B2/ja active Active
- 2013-08-22 EP EP13830452.2A patent/EP2888252B1/en active Active
- 2013-08-22 NZ NZ705167A patent/NZ705167A/en unknown
- 2013-08-22 AU AU2013305663A patent/AU2013305663B2/en active Active
- 2013-08-22 WO PCT/US2013/056220 patent/WO2014031873A2/en active Application Filing
- 2013-08-23 WO PCT/US2013/056360 patent/WO2014031942A1/en active Application Filing
-
2015
- 2015-02-18 IL IL237305A patent/IL237305B/en active IP Right Grant
- 2015-02-19 ZA ZA2015/01161A patent/ZA201501161B/en unknown
-
2016
- 2016-03-24 US US15/080,036 patent/US20160264535A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL237305B (en) | 2018-08-30 |
| BR112015003824B1 (pt) | 2022-10-04 |
| JP6219955B2 (ja) | 2017-10-25 |
| WO2014031942A1 (en) | 2014-02-27 |
| MX365851B (es) | 2019-06-17 |
| US20160264535A1 (en) | 2016-09-15 |
| EP2888252B1 (en) | 2017-06-07 |
| AU2013305663B2 (en) | 2017-11-02 |
| RU2015110256A (ru) | 2016-10-10 |
| EP2888252A4 (en) | 2016-01-06 |
| CN104768949A (zh) | 2015-07-08 |
| KR20150046263A (ko) | 2015-04-29 |
| CA2883221C (en) | 2020-01-21 |
| ZA201501161B (en) | 2016-06-29 |
| KR102046499B1 (ko) | 2019-11-19 |
| MX2015002418A (es) | 2015-09-21 |
| AU2013305663A1 (en) | 2015-03-05 |
| RU2641293C2 (ru) | 2018-01-17 |
| US20150266838A1 (en) | 2015-09-24 |
| WO2014031873A2 (en) | 2014-02-27 |
| JP2015526475A (ja) | 2015-09-10 |
| EP2888252A2 (en) | 2015-07-01 |
| WO2014031873A3 (en) | 2014-04-17 |
| CA2883221A1 (en) | 2014-02-27 |
| US9328078B2 (en) | 2016-05-03 |
| IL237305A0 (en) | 2015-04-30 |
| NZ705167A (en) | 2017-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015006996A2 (pt) | método para reduzir a quantidade de enxofre em uma composição que compreende enxofre, e, composição. | |
| CL2015000177A1 (es) | Composición para el tratamiento de la hiperlipidemia que comprende un derivado de oxintomodulina | |
| CL2014003136A1 (es) | Nuevos diazaespirocicloalcanos y azaespirocicloalcanos; composicion farmaceutica que los contiene y usos. | |
| BR112016000489A2 (pt) | composto, composição farmacêutica que o compreende, uso da composição e métodos para fabricar compostos | |
| BR112015031475A2 (pt) | composto, composição farmacêutica, método para tratamento de uma doença ou condição, kit, e, uso de composto. | |
| BR112014029674A2 (pt) | composto, composição farmacêutica, método para o tratamento de uma doença, utilização de um composto, conjunto para o tratamento de uma condição mediada pela quinase pim e invenção | |
| CL2014001793A1 (es) | Compuestos derivados de 1,3,5-triazinas sustituidas y sus sales, como inhibidores de la idh2 mutante; composicion farmaceutica que los comprende; y su uso para el tratamiento del cancer. | |
| BR112014011671A2 (pt) | composto, composição farmacêutica, método para o tratamento de uma doença ou condição, e, uso de um composto | |
| ES2968043T3 (es) | Nuevos derivados de oxintomodulina y composición farmacéutica para el tratamiento de la obesidad que comprende la misma | |
| BR112014028647A2 (pt) | composições e métodos para modulação da expressão de bdnf | |
| BR112017027332A2 (pt) | composições tópicas que compreendem um corticosteróide e um retinóide para tratar psoríase. | |
| BR112015003824A2 (pt) | composto; método de tratamento de uma amiloidose em um indivíduo; composição farmacêutica; e método para tratar uma condição que é um membro selecionado da perda de memória, perda de cognição e uma combinação destas. | |
| CL2014002880A1 (es) | Compuestos derivados de heterociclos nitrogenados o sus sales, inhibidores selectivos de la pde2a; medicamento que los comprende; y su uso para la profilaxis y tratamiento de la esquizofrenia. | |
| BR112014008126A2 (pt) | composto, método para o tratamento, composição farmacêutica, utilização de um composto e invenção | |
| BR112012026570A2 (pt) | composto, composição farmacêutica, uso de um composto, método para o tratamento de um indíviduo e produto combinado | |
| CL2014002348A1 (es) | Compuestos derivados de fenicol; composicion farmaceutica que los comprende; y su uso para controlar o tratar infecciones bacterianas en ganado. | |
| BR112013018679A2 (pt) | agente para o tratamento da alopecia | |
| BR112014032510A2 (pt) | composto, composição farmacêutica, método para tratar ou prevenir uma doença ou desordem, e, uso de um composto. | |
| BR112014032053A2 (pt) | composto, composição farmacêutica, utilização de um composto, método para o tratamento de câncer e invenção | |
| BR112014031896A2 (pt) | composto, composição farmacêutica, e, método para o tratamento de um distúrbio | |
| BR112012027145A2 (pt) | emulsão, composição de uso final e método para tratar uma condição cutânea | |
| BR112015007214A8 (pt) | composto, método para a inibição da atividade da quinase, método para o tratamento, composição, utilização de um composto e invenção | |
| CL2014002978A1 (es) | Combinaciones farmacéuticas que contienen un inhibidor de 11-beta-hidroxiesteroide dehidrogenasa para el tratamiento de trastornos metabólicos | |
| BR112014031512A2 (pt) | composição cosmética e método para o tratamento cosmético. | |
| BR112014026795A2 (pt) | composição cosmética , processo cosmético para tratar a matéria queratínica e uso de uma composição cosmética. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B15I | Others concerning applications: loss of priority | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B12F | Other appeals [chapter 12.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: A CLASSIFICACAO ANTERIOR ERA: C07D 413/04 Ipc: A61K 31/4745 (2006.01), C07D 413/04 (2006.01), A61 |
|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/08/2013, OBSERVADAS AS CONDICOES LEGAIS |